245 related articles for article (PubMed ID: 21804090)
1. Activation of RhoA in podocytes induces focal segmental glomerulosclerosis.
Zhu L; Jiang R; Aoudjit L; Jones N; Takano T
J Am Soc Nephrol; 2011 Sep; 22(9):1621-30. PubMed ID: 21804090
[TBL] [Abstract][Full Text] [Related]
2. SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance.
Rogg M; Maier JI; Dotzauer R; Artelt N; Kretz O; Helmstädter M; Abed A; Sammarco A; Sigle A; Sellung D; Dinse P; Reiche K; Yasuda-Yamahara M; Biniossek ML; Walz G; Werner M; Endlich N; Schilling O; Huber TB; Schell C
J Am Soc Nephrol; 2021 Mar; 32(3):563-579. PubMed ID: 33514561
[TBL] [Abstract][Full Text] [Related]
3. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
4. Mice with mutant Inf2 show impaired podocyte and slit diaphragm integrity in response to protamine-induced kidney injury.
Subramanian B; Sun H; Yan P; Charoonratana VT; Higgs HN; Wang F; Lai KV; Valenzuela DM; Brown EJ; Schlöndorff JS; Pollak MR
Kidney Int; 2016 Aug; 90(2):363-372. PubMed ID: 27350175
[TBL] [Abstract][Full Text] [Related]
5. Rac1 activation in podocytes induces the spectrum of nephrotic syndrome.
Robins R; Baldwin C; Aoudjit L; Côté JF; Gupta IR; Takano T
Kidney Int; 2017 Aug; 92(2):349-364. PubMed ID: 28483380
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.
Feng D; Kumar M; Muntel J; Gurley SB; Birrane G; Stillman IE; Ding L; Wang M; Ahmed S; Schlondorff J; Alper SL; Ferrante T; Marquez SL; Ng CF; Novak R; Ingber DE; Steen H; Pollak MR
J Am Soc Nephrol; 2020 Jul; 31(7):1479-1495. PubMed ID: 32540856
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z
Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.
Fuchshofer R; Ullmann S; Zeilbeck LF; Baumann M; Junglas B; Tamm ER
Histochem Cell Biol; 2011 Sep; 136(3):301-19. PubMed ID: 21814837
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor of activated T cells mediates RhoA-induced fibronectin upregulation in glomerular podocytes.
Zhu L; Qi XY; Aoudjit L; Mouawad F; Baldwin C; Nattel S; Takano T
Am J Physiol Renal Physiol; 2013 Apr; 304(7):F849-62. PubMed ID: 23389455
[TBL] [Abstract][Full Text] [Related]
10. Gα12 activation in podocytes leads to cumulative changes in glomerular collagen expression, proteinuria and glomerulosclerosis.
Boucher I; Yu W; Beaudry S; Negoro H; Tran M; Pollak MR; Henderson JM; Denker BM
Lab Invest; 2012 May; 92(5):662-75. PubMed ID: 22249312
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the proteinuria induced by Rho GTPases.
Wang L; Ellis MJ; Gomez JA; Eisner W; Fennell W; Howell DN; Ruiz P; Fields TA; Spurney RF
Kidney Int; 2012 Jun; 81(11):1075-85. PubMed ID: 22278020
[TBL] [Abstract][Full Text] [Related]
12. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
13. Soluble RARRES1 induces podocyte apoptosis to promote glomerular disease progression.
Chen A; Feng Y; Lai H; Ju W; Li Z; Li Y; Wang A; Hong Q; Zhong F; Wei C; Fu J; Guan T; Liu B; Kretzler M; Lee K; He JC
J Clin Invest; 2020 Oct; 130(10):5523-5535. PubMed ID: 32634130
[TBL] [Abstract][Full Text] [Related]
14. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
15. The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice.
Smeets B; Te Loeke NA; Dijkman HB; Steenbergen ML; Lensen JF; Begieneman MP; van Kuppevelt TH; Wetzels JF; Steenbergen EJ
J Am Soc Nephrol; 2004 Apr; 15(4):928-39. PubMed ID: 15034095
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
[TBL] [Abstract][Full Text] [Related]
17. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
[TBL] [Abstract][Full Text] [Related]
18. Glomerular hypertrophy precedes albuminuria and segmental loss of podoplanin in podocytes in Munich-Wistar-Frömter rats.
Ijpelaar DH; Schulz A; Koop K; Schlesener M; Bruijn JA; Kerjaschki D; Kreutz R; de Heer E
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F758-67. PubMed ID: 18199599
[TBL] [Abstract][Full Text] [Related]
19. Podocyte Geranylgeranyl Transferase Type-I Is Essential for Maintenance of the Glomerular Filtration Barrier.
Boi R; Bergwall L; Ebefors K; Bergö MO; Nyström J; Buvall L
J Am Soc Nephrol; 2023 Apr; 34(4):641-655. PubMed ID: 36735952
[TBL] [Abstract][Full Text] [Related]
20. Antibody-induced albuminuria and accelerated focal glomerulosclerosis in the Thy-1.1 transgenic mouse.
Assmann KJ; van Son JP; Dïjkman HB; Mentzel S; Wetzels JF
Kidney Int; 2002 Jul; 62(1):116-26. PubMed ID: 12081570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
